Cargando…
B cells characterization in ADA2 Deficiency patients
Autores principales: | Schena, F, Volpi, S, Caorsi, R, Pastorino, C, Penco, F, Kalli, F, Omenetti, A, Chiesa, S, Bertoni, A, Picco, P, Filaci, G, Aksentijevich, I, Grossi, A, Ceccherini, I, Martini, A, Traggiai, E, Gattorno, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599900/ http://dx.doi.org/10.1186/1546-0096-13-S1-P65 |
Ejemplares similares
-
Long-term efficacy of etanercept in ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2014) -
Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency
por: Caorsi, R, et al.
Publicado: (2015) -
Monogenic polyarteritis: the lesson of ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2016) -
PReS-FINAL-2324: PAPA syndrome clinical spectrum and IL-1Β release
por: Omenetti, A, et al.
Publicado: (2013) -
Recruitment of abundant NK cells to the PFAPA tonsils support the crucial role of innate immunity in pathogenesis of PFAPA syndrome
por: Chiesa, S, et al.
Publicado: (2015)